[HTML][HTML] High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial
…, VG Soler, M Giménez, A París, S Marfil… - The Lancet …, 2022 - thelancet.com
Background Convalescent plasma has been proposed as an early treatment to interrupt the
progression of early COVID-19 to severe disease, but there is little definitive evidence. We …
progression of early COVID-19 to severe disease, but there is little definitive evidence. We …
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression
…, J Romeu, R Paredes, MK Zayat, S Marfil… - Aids, 2000 - journals.lww.com
Objective To investigate the virological and immunological impact of a structured treatment
interruption (STI) in a cohort of HIV-1 chronically infected patients with a further long-lasting …
interruption (STI) in a cohort of HIV-1 chronically infected patients with a further long-lasting …
[PDF][PDF] Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
E Pradenas, B Trinité, V Urrea, S Marfil, C Ávila-Nieto… - Med, 2021 - cell.com
Background Understanding mid-term kinetics of immunity to SARS-CoV-2 is the cornerstone
for public health control of the pandemic and vaccine development. However, current …
for public health control of the pandemic and vaccine development. However, current …
[HTML][HTML] SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
…, J Rodon, E Pradenas, V Urrea, S Marfil… - Scientific Reports, 2021 - nature.com
The protective effect of neutralizing antibodies in SARS-CoV-2 infected individuals is not yet
well defined. To address this issue, we have analyzed the kinetics of neutralizing antibody …
well defined. To address this issue, we have analyzed the kinetics of neutralizing antibody …
[HTML][HTML] An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
…, B Trinité, R Ortiz, E Pradenas, P Blanco, S Marfil… - npj Vaccines, 2023 - nature.com
Antigen display on the surface of Virus-Like Particles (VLPs) improves immunogenicity
compared to soluble proteins. We hypothesised that immune responses can be further improved …
compared to soluble proteins. We hypothesised that immune responses can be further improved …
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection
…, G Carcelain, J Martínez-Picado, S Frost, S Marfil… - Aids, 2001 - journals.lww.com
… Ruiz, Lidia a ; Carcelain, Guislaine b ; Martínez-Picado, Javier a ; Frost, Simon c ; Marfil,
Silvia a ; Paredes, Roger a ; Romeu, Joan a ; Ferrer, Esther a ; Morales-Lopetegi, Kristina a …
Silvia a ; Paredes, Roger a ; Romeu, Joan a ; Ferrer, Esther a ; Morales-Lopetegi, Kristina a …
Short Communication: Naive CD4+ T Cells and Recent Thymic Emigrant Levels in Treated Individuals with HIV: Clinical Relevance
…, R Ruiz-Hernandez, C Cabrera, S Marfil… - AIDS Research & …, 2006 - liebertpub.com
An increase in the levels of naive T cells after the administration of HAART is an indicator of
the quality of immune reconstitution. We investigated whether levels of naive CD4 T cells (…
the quality of immune reconstitution. We investigated whether levels of naive CD4 T cells (…
Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with⩽ 250/μL CD4 T cells and undetectable …
…, A Jou, M Balagué, MK Zayat, S Marfil… - The Journal of …, 1999 - academic.oup.com
The immunologic efficacy of low-dose recombinant interleukin-2 (rIL-2) administered sub-cutaneously
(sc) once a day in combination with highly active antiretroviral therapy (HAART) …
(sc) once a day in combination with highly active antiretroviral therapy (HAART) …
[PDF][PDF] Clinical course impacts early kinetics, magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
E Pradenas, B Trinité, V Urrea, S Marfil… - Cell Reports …, 2022 - cell.com
To understand the determinants of long-term immune responses to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the concurrent impact of vaccination and …
syndrome coronavirus 2 (SARS-CoV-2) and the concurrent impact of vaccination and …
[HTML][HTML] First detection of SARS-CoV-2 delta (B. 1.617. 2) variant of concern in a dog with clinical signs in Spain
Several cases of naturally infected dogs with severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) have been reported despite the apparently low susceptibility of this …
2 (SARS-CoV-2) have been reported despite the apparently low susceptibility of this …